T-Cell Vaccination in Multiple Sclerosis (MS)
The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase I/II Safety and Efficacy Trial
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- T-Cell Vaccination
What it measured
Main measures
safety assessment of T-cell vaccination in nonresponding MS patients
Safety
Who could take part
Relapsing and progressive · 16 to 60 · EDSS 0 to 6
Show the full criteria
Inclusion criteria
* Definite MS (post criteria) * Relapsing remitting or primary progressive clinical course. At least one relapse in the last two years. * Disease duration > 1 year * Expanded Disability Status Scale (EDSS) between 0-6 * Brain magnetic resonance imaging (MRI) compatible with MS * Not involved in any other clinical trials * No other systemic disease
Exclusion criteria
* Does not comply with the above
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study is to evaluate the safety of T-cell vaccination in MS patients.
Papers
Loading reviews and guidelines…
History
Started
Jul 1998
Finished
Dec 2007